MEDIORG
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Medicamen Organics Raises 30 Mln Rupees Through Convertible Warrants Issue
Jan 9 (Reuters) - Medicamen Organics Ltd MEDM.NS:
RAISES 30 MILLION RUPEES THROUGH CONVERTIBLE WARRANTS ISSUE
Source text: ID:nNSEQQYYr
Further company coverage: MEDM.NS
(([email protected];;))
Jan 9 (Reuters) - Medicamen Organics Ltd MEDM.NS:
RAISES 30 MILLION RUPEES THROUGH CONVERTIBLE WARRANTS ISSUE
Source text: ID:nNSEQQYYr
Further company coverage: MEDM.NS
(([email protected];;))
Medicamen Organics Approves Fund Raise Of 30 Mln Rupees
Jan 8 (Reuters) - Medicamen Organics Ltd MEDM.NS:
APPROVES FUND RAISE OF 30 MILLION RUPEES
Source text: ID:nNSE46924l
Further company coverage: MEDM.NS
(([email protected];;))
Jan 8 (Reuters) - Medicamen Organics Ltd MEDM.NS:
APPROVES FUND RAISE OF 30 MILLION RUPEES
Source text: ID:nNSE46924l
Further company coverage: MEDM.NS
(([email protected];;))
Medicamen Organics Announces Partnership With Medi Hub Organic
Dec 30 (Reuters) - Medicamen Organics Ltd MEDM.NS:
MEDICAMEN ORGANICS LTD - ANNOUNCES PARTNERSHIP WITH MEDI HUB ORGANIC
MEDICAMEN ORGANICS LTD - TO INVEST 90 MILLION RUPEES IN MEDI HUB ORGANIC
Source text: ID:nNSE6jVKVY
Further company coverage: MEDM.NS
(([email protected];))
Dec 30 (Reuters) - Medicamen Organics Ltd MEDM.NS:
MEDICAMEN ORGANICS LTD - ANNOUNCES PARTNERSHIP WITH MEDI HUB ORGANIC
MEDICAMEN ORGANICS LTD - TO INVEST 90 MILLION RUPEES IN MEDI HUB ORGANIC
Source text: ID:nNSE6jVKVY
Further company coverage: MEDM.NS
(([email protected];))
Medicamen Organics Announces Strategic Partnership With Medi Hub Organic
Dec 24 (Reuters) - Medicamen Organics Ltd MEDM.NS:
ANNOUNCES STRATEGIC PARTNERSHIP WITH MEDI HUB ORGANIC
MOL TO INVEST 90 MILLION RUPEES IN MHOL
MOL TO HOLD 30% STAKE IN MHOL
Source text: ID:nNSEc6wJGR
Further company coverage: MEDM.NS
(([email protected];;))
Dec 24 (Reuters) - Medicamen Organics Ltd MEDM.NS:
ANNOUNCES STRATEGIC PARTNERSHIP WITH MEDI HUB ORGANIC
MOL TO INVEST 90 MILLION RUPEES IN MHOL
MOL TO HOLD 30% STAKE IN MHOL
Source text: ID:nNSEc6wJGR
Further company coverage: MEDM.NS
(([email protected];;))
Medicamen Organics Gets New Order Worth 62.8 Million Rupees
Nov 18 (Reuters) - Medicamen Organics Ltd MEDM.NS:
MEDICAMEN ORGANICS LTD - GETS NEW ORDER WORTH 62.8 MILLION RUPEES
Source text: ID:nNSE2LNvh2
Further company coverage: MEDM.NS
(([email protected];;))
Nov 18 (Reuters) - Medicamen Organics Ltd MEDM.NS:
MEDICAMEN ORGANICS LTD - GETS NEW ORDER WORTH 62.8 MILLION RUPEES
Source text: ID:nNSE2LNvh2
Further company coverage: MEDM.NS
(([email protected];;))
Medicamen Organics Acquires 51% Stake In Depot Pharmacy Yego
Oct 8 (Reuters) - Medicamen Organics Ltd MEDM.NS:
ACQUIRES 51% STAKE IN DEPOT PHARMACY YEGO
SIGNS SHARE PURCHASE AGREEMENT FOR A SUBSIDIARY IN RWANDA
Source text for Eikon: [ID:]
Further company coverage: MEDM.NS
(([email protected];;))
Oct 8 (Reuters) - Medicamen Organics Ltd MEDM.NS:
ACQUIRES 51% STAKE IN DEPOT PHARMACY YEGO
SIGNS SHARE PURCHASE AGREEMENT FOR A SUBSIDIARY IN RWANDA
Source text for Eikon: [ID:]
Further company coverage: MEDM.NS
(([email protected];;))
Medicamen Organics Enters French West African Market Via Strategic MoU
Sept 24 (Reuters) - Medicamen Organics Ltd MEDM.NS:
ENTERS FRENCH WEST AFRICAN MARKET VIA STRATEGIC MOU
PARTNERSHIP WILL LEAD TO FORMATION OF GRANDE ETOILE PHARMACEUTICALS
Source text for Eikon: ID:nNSE2yrLlr
Further company coverage: MEDM.NS
(([email protected];;))
Sept 24 (Reuters) - Medicamen Organics Ltd MEDM.NS:
ENTERS FRENCH WEST AFRICAN MARKET VIA STRATEGIC MOU
PARTNERSHIP WILL LEAD TO FORMATION OF GRANDE ETOILE PHARMACEUTICALS
Source text for Eikon: ID:nNSE2yrLlr
Further company coverage: MEDM.NS
(([email protected];;))
Medicamen Organics Signs MoU With Depot Pharmacy Yego In Rwanda
July 15 (Reuters) - Medicamen Organics Ltd MEDM.NS:
SIGNS MOU WITH DEPOT PHARMACY YEGO IN RWANDA
CO WILL INVEST $75,000 IN TERMS OF CAPITAL AND PRODUCT REGISTRATION COST
Source text for Eikon: ID:nNSE2Z7VpJ
Further company coverage: MEDM.NS
(([email protected];))
July 15 (Reuters) - Medicamen Organics Ltd MEDM.NS:
SIGNS MOU WITH DEPOT PHARMACY YEGO IN RWANDA
CO WILL INVEST $75,000 IN TERMS OF CAPITAL AND PRODUCT REGISTRATION COST
Source text for Eikon: ID:nNSE2Z7VpJ
Further company coverage: MEDM.NS
(([email protected];))
India's Medicamen Organics surges 326% in debut trade
** Shares of Medicamen Organics MEDM.NS jump 325.6% in market debut to 144.7 rupees
** The pharma co opened at 137.85 rupees, a 305.4% premium to IPO price of 34 rupees
** Co raised 31 mln rupees ($371,675.90) in IPO via fresh issue of shares - prospectus
** MEDM to utilise IPO proceeds for product registration expenses, plant upgrade, capacity boost and to fund working capital requirements
** This week, DEE Development Engineers DEEV.NS Akme Fintrade AKMF.NS and Stanley Lifestyles STAY.NS surged between 11% to 66% in debut trade
($1 = 83.4060 Indian rupees)
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
** Shares of Medicamen Organics MEDM.NS jump 325.6% in market debut to 144.7 rupees
** The pharma co opened at 137.85 rupees, a 305.4% premium to IPO price of 34 rupees
** Co raised 31 mln rupees ($371,675.90) in IPO via fresh issue of shares - prospectus
** MEDM to utilise IPO proceeds for product registration expenses, plant upgrade, capacity boost and to fund working capital requirements
** This week, DEE Development Engineers DEEV.NS Akme Fintrade AKMF.NS and Stanley Lifestyles STAY.NS surged between 11% to 66% in debut trade
($1 = 83.4060 Indian rupees)
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
Events:
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Medicamen Organics do?
Medicamen Organics is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer.
Who are the competitors of Medicamen Organics?
Medicamen Organics major competitors are Adeshwar Meditex, Omkar Pharmachem, Unick Fix-A-Form, Chandra Bhagat Pharm, Medistep Healthcare, Sandu Pharmaceutical, Guj. Terce Lab. Market Cap of Medicamen Organics is ₹29 Crs. While the median market cap of its peers are ₹32 Crs.
Is Medicamen Organics financially stable compared to its competitors?
Medicamen Organics seems to be less financially stable compared to its competitors. Altman Z score of Medicamen Organics is 2.36 and is ranked 5 out of its 8 competitors.
Does Medicamen Organics pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Medicamen Organics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Medicamen Organics allocated its funds?
Companies resources are allocated to majorly unproductive assets like Accounts Receivable
How strong is Medicamen Organics balance sheet?
Balance sheet of Medicamen Organics is moderately strong.
Is the profitablity of Medicamen Organics improving?
Yes, profit is increasing. The profit of Medicamen Organics is ₹4.57 Crs for TTM, ₹4.05 Crs for Mar 2025 and ₹2.62 Crs for Mar 2024.
Is the debt of Medicamen Organics increasing or decreasing?
Yes, The net debt of Medicamen Organics is increasing. Latest net debt of Medicamen Organics is ₹12.76 Crs as of Sep-25. This is greater than Mar-25 when it was ₹4.49 Crs.
Is Medicamen Organics stock expensive?
Medicamen Organics is not expensive. Latest PE of Medicamen Organics is 7.23, while 3 year average PE is 20.16. Also latest EV/EBITDA of Medicamen Organics is 3.01 while 3yr average is 7.27.
Has the share price of Medicamen Organics grown faster than its competition?
Medicamen Organics has given lower returns compared to its competitors. Medicamen Organics has grown at ~-37.81% over the last 1yrs while peers have grown at a median rate of -35.0%
Is the promoter bullish about Medicamen Organics?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Medicamen Organics is 59.73% and last quarter promoter holding is 59.73%.
Are mutual funds buying/selling Medicamen Organics?
There is Insufficient data to gauge this.
